β Cell Dysfunction Versus Insulin Resistance in the Pathogenesis of Type 2 Diabetes in East Asians (original) (raw)

• IDF Diabetes Atlas 2014 Update Sixth Edition. Brussels: International Diabetes Federation; 2014.
• Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet. 2006;368:1681–8.
  Article PubMed Google Scholar
• Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA. 2009;301:2129–40.
  Article CAS PubMed Google Scholar
• Abate N, Chandalia M. The impact of ethnicity on type 2 diabetes. J Diabet Complicat. 2003;17:39–58.
  Article Google Scholar
• Ntuk UE, Gill JM, Mackay DF, Sattar N, Pell JP. Ethnic-specific obesity cutoffs for diabetes risk: cross-sectional study of 490,288 UK Biobank participants. Diabetes Care. 2014;37:2500–7. An original article clarifying that East Asians develop type 2 diabetes at lower body mass index compared to Caucasians through a large multi-ethnic cohort in the UK.
  Article PubMed Google Scholar
• Nakanishi S, Okubo M, Yoneda M, Jitsuiki K, Yamane K, et al. A comparison between Japanese-Americans living in Hawaii and Los Angeles and native Japanese: the impact of lifestyle westernization on diabetes mellitus. Biomed Pharmacother. 2004;58:571–7.
  Article CAS PubMed Google Scholar
• Fujimoto WY, Boyko EJ, Hayashi T, Kahn SE, Leonetti DL, et al. Risk factors for type 2 diabetes: lessons learned from Japanese Americans in Seattle. J Diabetes Investig. 2012;3:212–24. An important review describing characteristics of Japanese American’s diabetes which is highly relevant to discuss pathogenesis of type 2 diabetes among East Asians.
  Article PubMed Central PubMed Google Scholar
• Moller JB, Dalla Man C, Overgaard RV, Ingwersen SH, Tornoe CW, et al. Ethnic differences in insulin sensitivity, beta-cell function, and hepatic extraction between Japanese and Caucasians: a minimal model analysis. J Clin Endocrinol Metab. 2014;99:4273–80. An original article describing direct comparisons of insulin secretion and resistance, during intravenous glucose tolerance test, between Japanese and Caucasians.
  Article PubMed Google Scholar
• Moller JB, Pedersen M, Tanaka H, Ohsugi M, Overgaard RV, et al. Body composition is the main determinant for the difference in type 2 diabetes pathophysiology between Japanese and Caucasians. Diabetes Care. 2014;37:796–804. An original article describing direct comparisons of insulin secretion and resistance, during oral glucose tolerance test, between Japanese and Caucasians.
  Article PubMed Google Scholar
• Fukushima M, Suzuki H, Seino Y. Insulin secretion capacity in the development from normal glucose tolerance to type 2 diabetes. Diabetes Res Clin Pract. 2004;66S:S37–44.
  Article Google Scholar
• Sloan R. Ethnic distribution of diabetes mellitus in Hawaii. JAMA. 1963;183:419–24.
  Article CAS PubMed Google Scholar
• Kagan A, Harris BR, Winkelstein Jr W, Johnson KG, Kato H, et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristics. J Chron Dis. 1974;27:345–64.
  Article CAS PubMed Google Scholar
• West KM. Diabetes in American Indians and other native populations of the New World. Diabetes. 1974;23:841–55.
  Article CAS PubMed Google Scholar
• Olefsky JM. LIlly lecture 1980. Insulin resistance and insulin action. An in vitro and in vivo perspective. Diabetes. 1981;30:148–62.
  Article CAS PubMed Google Scholar
• McNeely MJ, Boyko EJ. Type 2 diabetes prevalence in Asian Americans: results of a national health survey. Diabetes Care. 2004;27:66–9.
  Article PubMed Google Scholar
• Fujimoto WY, Hershon K, Kinyoun J, Stolov W, Weinberg C, et al. Type II diabetes mellitus in Seattle and Tokyo. Tohoku J Exp Med. 1983;141(Suppl):133–9.
  Article PubMed Google Scholar
• Lyssenko V, Almgren P, Anevski D, Perfekt R, Lahti K, et al. Predictors of and longitudinal changes in insulin sensitivity and secretion preceding onset of type 2 diabetes. Diabetes. 2005;54:166–74.
  Article CAS PubMed Google Scholar
• Ogihara T, Mirmira RG. An islet in distress: beta cell failure in type 2 diabetes. J Diabetes Investig. 2010;1:123–33.
  PubMed Central CAS PubMed Google Scholar
• DeFronzo RA. Pathogenesis of type 2 diabetes mellitus. Med Clin North Am. 2004;88:787–835. ix.
  Article CAS PubMed Google Scholar
• Fukushima M, Usami M, Ikeda M, Nakai Y, Taniguchi A, et al. Insulin secretion and insulin sensitivity at different stages of glucose tolerance: a cross-sectional study of Japanese type 2 diabetes. Metabolism. 2004;53:831–5.
  Article CAS PubMed Google Scholar
• Kadowaki T, Miyake Y, Hagura R, Akanuma Y, Kajinuma H, et al. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia. 1984;26:44–9.
  Article CAS PubMed Google Scholar
• Iwahashi H, Okauchi Y, Ryo M, Noguchi M, Morita S, et al. Insulin-secretion capacity in normal glucose tolerance, impaired glucose tolerance, and diabetes in obese and non-obese Japanese patients. J Diabetes Investig. 2012;3:271–5.
  Article PubMed Central CAS PubMed Google Scholar
• Yabe D, Kuroe A, Watanabe K, Iwasaki M, Hamasaki A, et al. Early phase glucagon and insulin secretory abnormalities, but not incretin secretion, are similarly responsible for hyperglycemia after ingestion of nutrients. J Diabet Complicat. 2015;29(3):413–21.
• Seino Y, Taminato T, Goto Y, Ikeda M, Imura H. Comparative insulinogenic effect of glucose, arginine and glucagon in patients with diabetes mellitus, endocrine disorders and liver disease. Acta Diabetol. 1975;12(2):89–99.
  Article CAS Google Scholar
• Kosaka K, Kuzuya T, Akanuma Y, Hagura R. Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment. Diabetologia. 1980;18:23–8.
  Article CAS PubMed Google Scholar
• Seino Y, Goto Y, Kurahachi H, Sakurai H, Ikeda M. Alteration of plasma glucagon response to arginine after treatment in patients with diabetes mellitus, Cushing’s syndrome and hypothyroidism. Horm Metab Res. 1977;9:28–32.
  Article CAS PubMed Google Scholar
• Seino Y, Ikeda M, Kurahachi H, Taminato T, Sakurai H, et al. Failure of suppress plasma glucagon concentrations by orally administered glucose in diabetic patients after treatment. Diabetes. 1978;27:1145–50.
  Article CAS PubMed Google Scholar
• Tripathy D, Carlsson M, Almgren P, Isomaa B, Taskinen MR, et al. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes. 2000;49:975–80.
  Article CAS PubMed Google Scholar
• Kim DJ, Lee MS, Kim KW, Lee MK. Insulin secretory dysfunction and insulin resistance in the pathogenesis of Korean type 2 diabetes mellitus. Metabolism. 2001;50:590–3.
  Article CAS PubMed Google Scholar
• Choi YH, Ahn YB, Yoon KH, Kang MI, Cha BY, et al. New ADA criteria in the Korean population: fasting blood glucose is not enough for diagnosis of mild diabetes especially in the elderly. Korean J Intern Med. 2000;15:211–7.
  Article CAS PubMed Google Scholar
• Qian L, Xu L, Wang X, Fu X, Gu Y, et al. Early insulin secretion failure leads to diabetes in Chinese subjects with impaired glucose regulation. Diabetes Metab Res Rev. 2009;25:144–9.
  Article CAS PubMed Google Scholar
• Pang C, Bao YQ, Wang C, Lu JX, Jia WP, et al. Relationship between the level of fasting plasma glucose and beta cell functions in Chinese with or without diabetes. Chin Med J (Engl). 2008;121:2119–23.
  CAS Google Scholar
• Taniguchi A, Nakai Y, Fukushima M, Kawamura H, Imura H, et al. Pathogenic factors responsible for glucose intolerance in patients with NIDDM. Diabetes. 1992;41:1540–6.
  Article CAS PubMed Google Scholar
• Welch S, Gebhart SS, Bergman RN, Phillips LS. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab. 1990;71:1508–18.
  Article CAS PubMed Google Scholar
• Kodama K, Tojjar D, Yamada S, Toda K, Patel CJ, et al. Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis. Diabetes Care. 2013;36:1789–96.
  Article PubMed Central CAS PubMed Google Scholar
• Tanaka S, Horimai C, Katsukawa F. Ethnic differences in abdominal visceral fat accumulation between Japanese, African-Americans, and Caucasians: a meta-analysis. Acta Diabetol. 2003;40 Suppl 1:S302–4.
  Article PubMed Google Scholar
• DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 1998;317:371–75.
• Qiao Q, Nakagami T, Tuomilehto J, Borch-Johnsen K, Balkau B, et al. Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts. Diabetologia. 2000;43:1470–5.
  Article CAS PubMed Google Scholar
• Suzuki H, Fukushima M, Usami M, Ikeda M, Taniguchi A, et al. Factors responsible for development from normal glucose tolerance to isolated postchallenge hyperglycemia. Diabetes Care. 2003;26:1211–5.
  Article CAS PubMed Google Scholar
• Mitsui R, Fukushima M, Taniguchi A, Nakai Y, Aoyama S, et al. Insulin secretory capacity and insulin sensitivity in impaired fasting glucose in Japanese. J Diabetes Investig. 2012;3:377–83.
  Article PubMed Central CAS PubMed Google Scholar
• Nishi Y, Fukushima M, Suzuki H, Mitsui R, Ueda N, et al. Insulin secretion and insulin sensitivity in Japanese subjects with impaired fasting glucose and isolated fasting hyperglycemia. Diabetes Res Clin Pract. 2005;70:46–52.
  Article CAS PubMed Google Scholar
• Nakagami T, Qiao Q, Carstensen B, Nhr-Hansen C, Hu G, et al. Age, body mass index and type 2 diabetes-associations modified by ethnicity. Diabetologia. 2003;46:1063–70.
  Article CAS PubMed Google Scholar
• Fujimoto WY, Leonetti DL, Kinyoun JL, Shuman WP, Stolov WC, et al. Prevalence of complications among second-generation Japanese-American men with diabetes, impaired glucose tolerance, or normal glucose tolerance. Diabetes. 1987;36:730–9.
  Article CAS PubMed Google Scholar
• Fujimoto WY, Leonetti DL, Kinyoun JL, Newell-Morris L, Shuman WP, et al. Prevalence of diabetes mellitus and impaired glucose tolerance among second-generation Japanese-American men. Diabetes. 1987;36:721–9.
  Article CAS PubMed Google Scholar
• Matsubara T, Mita A, Minami K, Hosooka T, Kitazawa S, et al. PGRN is a key adipokine mediating high fat diet-induced insulin resistance and obesity through IL-6 in adipose tissue. Cell Metab. 2012;15:38–50.
  Article CAS PubMed Google Scholar
• Yasuda K, Miyake K, Horikawa Y, Hara K, Osawa H, et al. Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus. Nat Genet. 2008;40:1092–7.
  Article CAS PubMed Google Scholar
• Unoki H, Takahashi A, Kawaguchi T, Hara K, Horikoshi M, et al. SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet. 2008;40:1098–102.
  Article CAS PubMed Google Scholar
• Ullrich S, Su J, Ranta F, Wittekindt OH, Ris F, et al. Effects of I(Ks) channel inhibitors in insulin-secreting INS-1 cells. Pflugers Arch. 2005;451:428–36.
  Article CAS PubMed Google Scholar
• Yamauchi T, Hara K, Maeda S, Yasuda K, Takahashi A, et al. A genome-wide association study in the Japanese population identifies susceptibility loci for type 2 diabetes at UBE2E2 and C2CD4A-C2CD4B. Nat Genet. 2010;42:864–8.
  Article CAS PubMed Google Scholar
• Kimura M, Hattori T, Matsuda Y, Yoshioka T, Sumi N, et al. cDNA cloning, characterization, and chromosome mapping of UBE2E2 encoding a human ubiquitin-conjugating E2 enzyme. Cytogenet Cell Genet. 1997;78:107–11.
  Article CAS PubMed Google Scholar
• Tsai FJ, Yang CF, Chen CC, Chuang LM, Lu CH, et al. A genome-wide association study identifies susceptibility variants for type 2 diabetes in Han Chinese. PLoS Genet. 2010;6:e1000847.
  Article PubMed Central PubMed Google Scholar
• Shu XO, Long J, Cai Q, Qi L, Xiang YB, et al. Identification of new genetic risk variants for type 2 diabetes. PLoS Genet. 2010;6:e1001127.
  Article PubMed Central PubMed Google Scholar
• Wolosker H, Blackshaw S, Snyder SH. Serine racemase: a glial enzyme synthesizing D-serine to regulate glutamate-N-methyl-D-aspartate neurotransmission. Proc Natl Acad Sci U S A. 1999;96:13409–14.
  Article PubMed Central CAS PubMed Google Scholar
• Gonoi T, Mizuno N, Inagaki N, Kuromi H, Seino Y, et al. Functional neuronal ionotropic glutamate receptors are expressed in the non-neuronal cell line MIN6. J Biol Chem. 1994;269:16989–92.
  CAS PubMed Google Scholar
• Cho YS, Chen CH, Hu C, Long J, Ong RT, et al. Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in East Asians. Nat Genet. 2012;44:67–72.
  Article CAS Google Scholar
• Hwang JY, Sim X, Wu Y, Liang J, Tabara Y, et al. Genome-wide association meta-analysis identifies novel variants associated with fasting plasma glucose in East Asians. Diabetes. 2015;64(1):291–8.
• Neel JV. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet. 1962;14:353–62.
  PubMed Central CAS PubMed Google Scholar
• Southam L, Soranzo N, Montgomery SB, Frayling TM, McCarthy MI, et al. Is the thrifty genotype hypothesis supported by evidence based on confirmed type 2 diabetes- and obesity-susceptibility variants? Diabetologia. 2009;52:1846–51.
  Article PubMed Central CAS PubMed Google Scholar
• Cho YS, Lee JY, Park KS, Nho CW. Genetics of type 2 diabetes in East Asian populations. Curr Diabetes Rep. 2012;12:686–96.
  Article Google Scholar
• Nauck MA, Homberger E, Siegel EG, Allen RC, Eaton RP, et al. Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses. J Clin Endocrinol Metab. 1986;63:492–8.
  Article CAS PubMed Google Scholar
• Knop FK, Vilsboll T, Hojberg PV, Larsen S, Madsbad S, et al. Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state? Diabetes. 2007;56:1951–9.
  Article CAS PubMed Google Scholar
• Bagger JI, Knop FK, Lund A, Vestergaard H, Holst JJ, et al. Impaired regulation of the incretin effect in patients with type 2 diabetes. J Clin Endocrinol Metab. 2011;96:737–45.
  Article CAS PubMed Google Scholar
• Seino Y, Fukushima M, Yabe D. GIP and GLP-1, the two incretin hormones: similarities and differences. J Diabetes Investig. 2010;1:9–23.
  Google Scholar
• Yabe D, Seino Y. Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and beta cell preservation. Prog Biophys Mol Biol. 2011;107:248–56.
  Article CAS PubMed Google Scholar
• Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87:1409–39.
  Article CAS PubMed Google Scholar
• Drucker DJ. Incretin action in the pancreas: potential promise, possible perils, and pathological pitfalls. Diabetes. 2013;62:3316–23. A useful review of intra- and extrapancreatic actions of glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1, which is highly relevant to discuss efficacy and safety of incretin-based therapies in the management of type 2 diabetes.
  Article PubMed Central CAS PubMed Google Scholar
• Seino Y, Yabe D. GIP and GLP-1: incretin actions beyond pancreas. J Diabetes Investig. 2013;4:108–30.
  Article PubMed Central CAS PubMed Google Scholar
• Calanna S, Christensen M, Holst JJ, Laferrere B, Gluud LL, et al. Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies. Diabetologia. 2013;56:965–72. An important systematic review and meta-analysis comparing secretion of glucagon-like peptide-1 between subjects with type 2 diabetes and normal glucose-tolerance.
  Article PubMed Central CAS PubMed Google Scholar
• Calanna S, Christensen M, Holst JJ, Laferrere B, Gluud LL, et al. Secretion of glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes: systematic review and meta-analysis of clinical studies. Diabetes Care. 2013;36:3346–52. An important systematic review and meta-analysis comparing secretion of glucose-dependent insulinotropic polypeptide between subjects with type 2 diabetes and normal glucose-tolerance.
  Article PubMed Central CAS PubMed Google Scholar
• Nauck MA, Vardarli I, Deacon CF, Holst JJ, Meier JJ. Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down? Diabetologia. 2011;54(1):10–8.
• Yabe D, Kuroe A, Lee S, Watanabe K, Hyo T, et al. Little enhancement of meal-induced GLP-1 secretion in Japanese: comparison of type 2 diabetes and healthy controls. J Diabetes Investig. 2010;1:56–9.
  Article PubMed Central CAS PubMed Google Scholar
• Kozawa J, Okita K, Imagawa A, Iwahashi H, Holst JJ, et al. Similar incretin secretion in obese and non-obese Japanese subjects with type 2 diabetes. Biochem Biophys Res Commun. 2010;393:410–3.
  Article CAS PubMed Google Scholar
• Lee S, Yabe D, Nohtomi K, Takada M, Morita R, et al. Intact glucagon-like peptide-1 levels are not decreased in Japanese patients with type 2 diabetes. Endocr J. 2010;57:119–26.
  Article CAS PubMed Google Scholar
• Oh TJ, Park KS, Cho YM. Correlation of the incretin effect with first- and second-phase insulin secretions in Koreans with various glucose tolerance statuses. Clin Endocrinol (Oxf). 2014. doi:10.1111/cen.12623.
• Oh TJ, Kim MY, Shin JY, Lee JC, Kim S, et al. The incretin effect in Korean subjects with normal glucose tolerance or type 2 diabetes. Clin Endocrinol (Oxf). 2014;80:221–7.
  Article CAS Google Scholar
• Yabe D, Watanabe K, Sugawara K, Kuwata H, Kitamoto Y, et al. Comparison of incretin immunoassays with or without plasma extraction: incretin secretion in Japanese patients with type 2 diabetes. J Diabetes Investig. 2012;3:70–9.
  Article PubMed Central CAS PubMed Google Scholar
• Vollmer K, Holst JJ, Baller B, Ellrichmann M, Nauck MA, et al. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes. 2008;57:678–87.
  Article CAS PubMed Google Scholar
• Vilsboll T, Krarup T, Madsbad S, Holst JJ. Defective amplification of the late phase insulin response to glucose by GIP in obese type II diabetic patients. Diabetologia. 2002;45:1111–9.
  Article CAS PubMed Google Scholar
• Saxena R, Hivert MF, Langenberg C, Tanaka T, Pankow JS, et al. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet. 2010;42:142–8.
  Article PubMed Central CAS PubMed Google Scholar
• Hamasaki A, Harada N, Muraoka A, Yamane S, Joo E, et al. Not glucose tolerance but obesity impairs the numerical incretin effect in Japanese subjects. Diabetologia. 2011;54:S217.
  Google Scholar
• Gheni G, Ogura M, Iwasaki M, Yokoi N, Minami K, et al. Glutamate acts as a key signal linking glucose metabolism to incretin/cAMP action to amplify insulin secretion. Cell Rep. 2014;9:661–73.
  Article CAS PubMed Google Scholar
• Park H, Park C, Kim Y, Rascati KL. Efficacy and safety of dipeptidyl peptidase-4 inhibitors in type 2 diabetes: meta-analysis. Ann Pharmacother. 2012;46:1453–69.
  Article PubMed Google Scholar
• Kim YG, Hahn S, Oh TJ, Kwak SH, Park KS, et al. Differences in the glucose-lowering efficacy of dipeptidyl peptidase-4 inhibitors between Asians and Non-Asians: a systematic review and meta-analysis. Diabetologia. 2013;56:696–708. An important systematic review and meta-analysis comparing glucose-lowering effects of dipeptidyl-peptidase-4 inhibitors between Asians and non-Asians.
  Article CAS PubMed Google Scholar
• Kim YG, Hahn S, Oh TJ, Park KS, Cho YM. Differences in the HbA1c-lowering efficacy of glucagon-like peptide-1 analogues between Asians and non-Asians: a systematic review and meta-analysis. Diabetes Obes Metab. 2014;16(10):900–9.An important systematic review and meta-analysis comparing glucose-lowering effects of glucagon-like peptide-1 between Asians and non-Asians.
• Kubota A, Matsuba I, Saito T, Nabe K, Seino Y. Secretory units of islets in transplantation index is a useful clinical marker to evaluate the efficacy of sitagliptin in treatment of type 2 diabetes mellitus. J Diabetes Investig. 2011;2:377–80.
  Article PubMed Central CAS PubMed Google Scholar
• Seino Y, Rasmussen MF, Clauson P, Kaku K. The once-daily human glucagon-like peptide-1 analog, liraglutide, improves β-cell function in Japanese patients with type 2 diabetes. J Diabetes Investig. 2012;3:388–95.
  Article PubMed Central CAS PubMed Google Scholar
• Iwasaki M, Hoshian F, Tsuji T, Hirose N, Matsumoto T, et al. Predicting efficacy of DPP-4 inhibitors in patients with type 2 diabetes: association of HbA1c reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels. J Diabetes Investig. 2012;3:464–7. An original article identifying a novel interaction of dietary habits and HbA1c-lowering of dipeptidyl-peptidase-4 inhibitors.
  Article PubMed Central CAS PubMed Google Scholar
• Senmaru T, Fukui M, Kobayashi K, Iwase H, Inada S, et al. Dipeptidyl-peptidase IV inhibitor is effective in patients with type 2 diabetes with high serum eicosapentaenoic acid concentrations. J Diabetes Investig. 2012;3:498–502.
  Article PubMed Central CAS PubMed Google Scholar
• Yabe D, Kuwata H, Iwasaki M, Usui R, Kurose T, et al. Effects of fish or meat intake before and after rice on postprandial glucose excursions and incretin secretion in type 2 diabetes: meal sequence as a novel target in dietary therapies for diabetes. Diabetes. 2014;64:LB12.
  Google Scholar
• Kubota A, Yabe D, Kanamori A, Kuroe A, Takahashi N, et al. Factors influencing the durability of the glucose-lowering effect of sitagliptin combined with a sulfonylurea. J Diabetes Investig. 2014;5:445–8.
  Article PubMed Central CAS PubMed Google Scholar
• Kanamori A, Matsuba I. Factors associated with reduced efficacy of sitagliptin therapy: analysis of 93 patients with type 2 diabetes treated for 1.5 years or longer. J Clin Med Res. 2013;5:217–21.
  PubMed Central PubMed Google Scholar
• Yabe D, Kuwata H, Kaneko M, Ito C, Nishikino R, et al. Use of the Japanese health insurance claims database to assess the risk of acute pancreatitis in patients with diabetes: comparison of DPP-4 inhibitors with other oral antidiabetic drugs. Diabetes Obes Metab. 2015;17(4):430–34.
• Kohro T, Yamazaki T, Sato H, Harada K, Ohe K, et al. Trends in antidiabetic prescription patterns in Japan from 2005 to 2011. Int Heart J. 2013;54:93–7.
  Article PubMed Google Scholar
• Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2012;55:1577–96.
  Article CAS PubMed Google Scholar
• Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35:1364–79.
  Article PubMed Central CAS PubMed Google Scholar
• Yabe D, Seino Y. Dipeptidyl peptidase-4 inhibitors and sulfonylureas for type 2 diabetes: friend or foe? J Diabetes Investig. 2014;5:475–7. An article comparing incidence of severe hypoglycemia by dipeptidyl peptidase-4 inhibitors in Japan and the USA.
  Article PubMed Central CAS PubMed Google Scholar
• Takahashi H, Shibasaki T, Park JH, Hidaka S, Takahashi T, et al. Role of Epac2A/Rap1 signaling in interplay between incretin and sulfonylurea in insulin secretion. Diabetes. 2015;64(4):1262–72.
• Shibasaki T, Takahashi T, Takahashi H, Seino S. Cooperation between cAMP signalling and sulfonylurea in insulin secretion. Diabetes Obes Metab. 2014;16 Suppl 1:118–25.
  Article CAS PubMed Google Scholar
• Takahashi T, Shibasaki T, Takahashi H, Sugawara K, Ono A, et al. Antidiabetic sulfonylureas and cAMP cooperatively activate Epac2A. Sci Signal. 2013;6:ra94.
  PubMed Google Scholar
• Mukai E, Fujimoto S, Sato H, Oneyama C, Kominato R, et al. Exendin-4 suppresses SRC activation and reactive oxygen species production in diabetic Goto-Kakizaki rat islets in an Epac-dependent manner. Diabetes. 2010;60:218–26.
  Article PubMed Central PubMed Google Scholar